Skeletal Muscular Swedish Mutant APP in Alzheimer's Disease Development
瑞典骨骼肌突变体 APP 在阿尔茨海默病发展中的作用
基本信息
- 批准号:10513298
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-10-01 至 2025-09-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationActinsAction PotentialsAdultAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloidAmyloid beta-Protein PrecursorAnimal Disease ModelsBehaviorBlood CirculationBody Weight decreasedBrainBrain PathologyCCL1 geneCDKN2A geneCXCL13 geneCXCL2 geneCell AgingCellsChronicCognitive deficitsDefectDementiaDenervationDevelopmentDiagnosisDiseaseDisease ProgressionEarly Onset Alzheimer DiseaseEncephalitisExhibitsGalactosidaseGenesGliosisGoalsGrowth FactorHippocampusHomeostasisHumanIL6 geneImpairmentInflammationInflammatoryIronLate Onset Alzheimer DiseaseLightLinkLoxP-flanked alleleMaintenanceMental DepressionMetabolismMusMuscleMuscle CellsMuscle WeaknessMuscle functionMutationNeurofibrillary TanglesNeurogliaNeuromuscular JunctionPathogenesisPathogenicityPathologicPhenotypePlasmaPopulationProcessResearchRoleSenile PlaquesSerumSeveritiesSkeletal MuscleSkeletal boneTP53 geneTestingTg2576Therapeutic InterventionThinnessTimeTissuesTransfectionTransgenesTransgenic MiceVeteransbrain cellcell growthcell typecerebrovascular amyloidchemokinecytokinegenetic risk factorhepcidinmouse modelmuscle agingmuscle degenerationmuscle formmuscle strengthmuscular structuremutantneurogenesisneuron lossnovelpeptide hormonepromoterrisk variantsarcopeniaselective expressionsenescenceskeletalskeletal muscle wastingtau-1
项目摘要
The goal of this proposal is to investigate possible contributions of Swedish mutant amyloid precursor protein
(APPswe) in skeletal muscles to the pathogenesis of Alzheimer’s disease (AD). App is a Mendelian gene for
early-onset AD. Swedish mutations in App favor APP cleavage to generate -amyloid (A). Much research on
AD has thus been focused on the impact of A on the brain, even though App and other AD risk genes are
known to be expressed not only in the brain, but also in periphery tissues.
Here, we asked if altered APP metabolism in skeletal muscles has any contribution to AD-relevant brain
pathology, and if so, what are the underlying mechanisms, for the following reasons. First, although AD is
pathologically characterized by cortical and cerebrovascular A plaques, phospho-tau containing neurofibrillary
tangles, reactive glial cell-associated chronic brain inflammation, and hippocampal neuronal loss, AD patients
often have lower lean-mass (mass of skeletal muscle and bone) and weight-loss, which are associated with the
severity of dementia and AD progression. Second, examinations of skeletal muscle structures in Tg2576, a
well-characterized AD animal model that expresses APPswe ubiquitously and develops some AD-relevant brain-
pathologic deficits, revealed muscle-weakness phenotype as early as 3-MO (month old), months before
any brain-pathologic defect that can be detected. Third, in addition to Tg2576, we generated
a conditional transgenic mouse model capable of cell-type specific expression of APPswe in Cre-dependent
manner. Selective expression of APPswe in skeletal muscles by crossing floxed APPswe transgene with human
skeletal -actin (HSA) promoter driven Cre (TgAPPsweHSA) resulted in not only muscle deficits [e.g., reduced
compound muscle action potential (CMAP) and increased denervation at neuromuscular junction (NMJ) at 3-
MO], but also brain phenotypes (e.g., impaired hippocampal neurogenesis at 3-MO and increased reactive
gliosis in cortex of 7-MO). These results demonstrate not only a cell autonomous role of APPswe in
suppressing adult NMJ maintenance and accelerating skeletal muscle aging, but also a cell-non-autonomous
role in the brain. Fourth, to understand how muscle APPswe affects brain cells, we characterized APPswe+
muscles and muscle cells (C2C12) expressing APPswe, and observed an elevation of cellular senescence,
including increases in p16Ink4a and senescence associated -galactosidase (SA--Gal) and a decrease in
C2C12 cell growth. The factors of senescence associated secretary phenotype (SASP) were also increased in
TgAPPsweHSA muscles and their circulation blood.
In light of these observations, we hypothesize that APPswe expression in skeletal muscles may
contribute to AD pathology by increasing muscle senescence and SASP factors. We will test this
hypothesis by the accomplishment of the following three specific aims. In Aim 1, we will test the hypothesis
that APPswe in skeletal muscles increases brain cell senescence and promotes AD-relevant deficits in the brain.
In Aim 2, we will test the hypothesis that increased muscle cellular senescence contributes to NMJ and brain
deficits in TgAPPsweHSA mice. In Aim 3, we will test the hypothesis that SASP factors, such as hepcidin, from
APPswe-expressing muscles are necessary for brain cell senescence and AD pathology.
It is our hope that the results will reveal a novel link of muscular APPswe with AD brain pathology, a
prerequisite to develop better diagnosis and therapeutic intervention for AD that occurs at higher rate among
veterans.
这项提议的目标是调查瑞典突变的淀粉样前体蛋白的可能贡献。
骨骼肌中的APPswe与阿尔茨海默病(AD)的发病机制有关。APP是孟德尔式的基因
早发性AD。瑞典的APP突变有利于APP的切割产生-淀粉样蛋白(A)。对……的大量研究
因此,AD一直专注于A对大脑的影响,尽管APP和其他AD风险基因
已知不仅在大脑中表达,而且在外周组织中也有表达。
在这里,我们询问骨骼肌中APP代谢的改变是否对AD相关的大脑有任何贡献
病理学,如果是这样,潜在的机制是什么,原因如下。首先,尽管AD是
病理特征为皮质和脑血管A-斑块,含有神经原纤维的磷酸-tau
阿尔茨海默病患者的缠结、反应性胶质细胞相关性慢性脑炎和海马神经元丢失
通常有较低的瘦身质量(骨骼肌肉和骨骼的质量)和体重减轻,这与
痴呆症的严重程度和AD的进展。第二,Tg2576中骨骼肌结构的检查,a
无处不在表达APPsWE并发育出一些与AD相关的大脑的AD动物模型-
病理缺陷,早在3-MO(一个月大)之前几个月就表现出肌肉无力的表型
任何可以检测到的脑部病理缺陷。第三,除了Tg2576之外,我们还生成了
Cre依赖性APPsWE细胞类型特异性表达的条件性转基因小鼠模型
举止。APPsWE基因与人杂交后在骨骼肌中的选择性表达
骨骼-肌动蛋白(HSA)启动子驱动的Cre(TgAPPSweHSA)不仅导致肌肉缺陷[例如,减少
复合肌肉动作电位(CMAP)和神经肌肉接头(NMJ)失神经增加
Mo],但也有脑表型(例如,3-MO时海马神经发生受损和反应性增加
7-MO组大鼠大脑皮质胶质细胞增多)。这些结果不仅证明了APPsWE在细胞中的自主作用
抑制成人NMJ维持和加速骨骼肌衰老,也是一种非自主性细胞
在大脑中扮演的角色。第四,为了了解肌肉APPswe如何影响脑细胞,我们将APPswe+
肌肉和肌肉细胞(C2C12)表达APPsWE,并观察到细胞衰老的增加,
包括p16INK4a和衰老相关-半乳糖苷酶(SA--Gal)的增加和
C2C12细胞生长。衰老相关分泌表型(SASP)的因子也增加了
TgAPP扫描HSA肌肉及其循环血液。
根据这些观察,我们假设APPsWE在骨骼肌中的表达可能
通过增加肌肉衰老和SASP因子参与AD病理。我们将对此进行测试
假设是通过实现以下三个具体目标实现的。在目标1中,我们将检验假设
骨骼肌中的APPswe增加了脑细胞的衰老,并促进了大脑中与AD相关的缺陷。
在目标2中,我们将检验肌肉细胞衰老增加对NMJ和大脑有贡献的假设
TgAPPSweHSA小鼠的缺陷。在目标3中,我们将检验这样的假设,即SASP因子,如海普西丁,来自
APPswe表达的肌肉是脑细胞衰老和AD病理所必需的。
我们希望这些结果将揭示肌肉APPsWE与AD脑病理的新联系,A
开发更好的AD诊断和治疗干预的先决条件
退伍军人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEN-CHENG XIONG其他文献
WEN-CHENG XIONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEN-CHENG XIONG', 18)}}的其他基金
Skeletal Muscular Swedish Mutant APP in Alzheimer's Disease Development
瑞典骨骼肌突变体 APP 在阿尔茨海默病发展中的作用
- 批准号:
10254624 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
- 批准号:
9605932 - 财政年份:2017
- 资助金额:
-- - 项目类别:
APP as a common denominator for Alzheimer's disease and osteoporosis
APP 是阿尔茨海默病和骨质疏松症的共同点
- 批准号:
9903240 - 财政年份:2016
- 资助金额:
-- - 项目类别:
APP as a common denominator for Alzheimer's disease and osteoporosis
APP 是阿尔茨海默病和骨质疏松症的共同点
- 批准号:
9607371 - 财政年份:2016
- 资助金额:
-- - 项目类别:
APP as a common denominator for Alzheimer's disease and osteoporosis
APP 是阿尔茨海默病和骨质疏松症的共同点
- 批准号:
9323223 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
- 批准号:
9059562 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
- 批准号:
9486649 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
- 批准号:
8708256 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Retromer deficiency and Alzheimer's disease pathology
逆转录酶缺乏与阿尔茨海默病病理学
- 批准号:
8842912 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
-- - 项目类别:














{{item.name}}会员




